274 related articles for article (PubMed ID: 32441016)
1. Somatic mutations of triple-negative breast cancer: a comparison between Black and White women.
Omilian AR; Wei L; Hong CC; Bandera EV; Liu S; Khoury T; Ambrosone CB; Yao S
Breast Cancer Res Treat; 2020 Jul; 182(2):503-509. PubMed ID: 32441016
[TBL] [Abstract][Full Text] [Related]
2. Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
Ademuyiwa FO; Tao Y; Luo J; Weilbaecher K; Ma CX
Breast Cancer Res Treat; 2017 Feb; 161(3):491-499. PubMed ID: 27915434
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
Keenan T; Moy B; Mroz EA; Ross K; Niemierko A; Rocco JW; Isakoff S; Ellisen LW; Bardia A
J Clin Oncol; 2015 Nov; 33(31):3621-7. PubMed ID: 26371147
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
Huo D; Hu H; Rhie SK; Gamazon ER; Cherniack AD; Liu J; Yoshimatsu TF; Pitt JJ; Hoadley KA; Troester M; Ru Y; Lichtenberg T; Sturtz LA; Shelley CS; Benz CC; Mills GB; Laird PW; Shriver CD; Perou CM; Olopade OI
JAMA Oncol; 2017 Dec; 3(12):1654-1662. PubMed ID: 28472234
[TBL] [Abstract][Full Text] [Related]
5. Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer.
Sturtz LA; Melley J; Mamula K; Shriver CD; Ellsworth RE
BMC Cancer; 2014 Feb; 14():62. PubMed ID: 24495414
[TBL] [Abstract][Full Text] [Related]
6. Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis.
Ma H; Ursin G; Xu X; Lee E; Togawa K; Duan L; Lu Y; Malone KE; Marchbanks PA; McDonald JA; Simon MS; Folger SG; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L
Breast Cancer Res; 2017 Jan; 19(1):6. PubMed ID: 28086982
[TBL] [Abstract][Full Text] [Related]
7. The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers.
Barrett MT; Lenkiewicz E; Malasi S; Basu A; Yearley JH; Annamalai L; McCullough AE; Kosiorek HE; Narang P; Wilson Sayres MA; Chen M; Anderson KS; Pockaj BA
Breast Cancer Res; 2018 Jul; 20(1):71. PubMed ID: 29996881
[TBL] [Abstract][Full Text] [Related]
8. Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer.
Sheppard VB; Cavalli LR; Dash C; Kanaan YM; Dilawari AA; Horton S; Makambi KH
Clin Breast Cancer; 2017 Jun; 17(3):232-238. PubMed ID: 28189497
[TBL] [Abstract][Full Text] [Related]
9. Update on triple-negative breast cancer disparities for the United States: A population-based study from the United States Cancer Statistics database, 2010 through 2014.
Scott LC; Mobley LR; Kuo TM; Il'yasova D
Cancer; 2019 Oct; 125(19):3412-3417. PubMed ID: 31282032
[TBL] [Abstract][Full Text] [Related]
10. Triple-negative breast cancer in African-American women: disparities versus biology.
Dietze EC; Sistrunk C; Miranda-Carboni G; O'Regan R; Seewaldt VL
Nat Rev Cancer; 2015 Apr; 15(4):248-54. PubMed ID: 25673085
[TBL] [Abstract][Full Text] [Related]
11. Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations.
Guerini-Rocco E; Piscuoglio S; Ng CK; Geyer FC; De Filippo MR; Eberle CA; Akram M; Fusco N; Ichihara S; Sakr RA; Yatabe Y; Vincent-Salomon A; Rakha EA; Ellis IO; Wen YH; Weigelt B; Schnitt SJ; Reis-Filho JS
J Pathol; 2016 Apr; 238(5):677-88. PubMed ID: 26806567
[TBL] [Abstract][Full Text] [Related]
12. Comparison of mutational profiles between triple-negative and hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancers in T2N0-1M0 stage: Implications of TP53 and PIK3CA mutations in Korean early-stage breast cancers.
Lee S; Kim HY; Jung YJ; Jung CS; Im D; Kim JY; Lee SM; Oh SH
Curr Probl Cancer; 2022 Apr; 46(2):100843. PubMed ID: 35180531
[TBL] [Abstract][Full Text] [Related]
13. Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women.
Sugita B; Gill M; Mahajan A; Duttargi A; Kirolikar S; Almeida R; Regis K; Oluwasanmi OL; Marchi F; Marian C; Makambi K; Kallakury B; Sheahan L; Cavalli IJ; Ribeiro EM; Madhavan S; Boca S; Gusev Y; Cavalli LR
Oncotarget; 2016 Nov; 7(48):79274-79291. PubMed ID: 27813494
[TBL] [Abstract][Full Text] [Related]
14. Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors.
Prakash O; Hossain F; Danos D; Lassak A; Scribner R; Miele L
Front Public Health; 2020; 8():576964. PubMed ID: 33415093
[TBL] [Abstract][Full Text] [Related]
15. Health Disparities and Triple-Negative Breast Cancer in African American Women: A Review.
Newman LA; Kaljee LM
JAMA Surg; 2017 May; 152(5):485-493. PubMed ID: 28355428
[TBL] [Abstract][Full Text] [Related]
16. Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.
O'Meara T; Safonov A; Casadevall D; Qing T; Silber A; Killelea B; Hatzis C; Pusztai L
Breast Cancer Res Treat; 2019 May; 175(1):247-259. PubMed ID: 30725384
[TBL] [Abstract][Full Text] [Related]
17. Triple-Negative Breast Cancer: A Comparison of Race and Survival.
Doepker MP; Holt SD; Durkin MW; Chu CH; Nottingham JM
Am Surg; 2018 Jun; 84(6):881-888. PubMed ID: 29981619
[TBL] [Abstract][Full Text] [Related]
18. Detection of PIK3/AKT pathway in Moroccan population with triple negative breast cancer.
Jouali F; Marchoudi N; Talbi S; Bilal B; El Khasmi M; Rhaissi H; Fekkak J
BMC Cancer; 2018 Sep; 18(1):900. PubMed ID: 30227836
[TBL] [Abstract][Full Text] [Related]
19. Early-onset triple-negative breast cancer in multiracial/ethnic populations: Distinct trends of prevalence of truncation mutations.
Liu Q; Yao S; Zhao H; Hu Q; Kwan ML; Roh JM; Ambrosone CB; Kushi LH; Liu S; Zhu Q
Cancer Med; 2019 Apr; 8(4):1845-1853. PubMed ID: 30864286
[TBL] [Abstract][Full Text] [Related]
20. Genomic analysis of racial differences in triple negative breast cancer.
Chang CS; Kitamura E; Johnson J; Bollag R; Hawthorn L
Genomics; 2019 Dec; 111(6):1529-1542. PubMed ID: 30366040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]